151 related articles for article (PubMed ID: 20975515)
1. Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.
Zhu CW; Livote EE; Kahle-Wrobleski K; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
Alzheimer Dis Assoc Disord; 2011; 25(2):144-8. PubMed ID: 20975515
[TBL] [Abstract][Full Text] [Related]
2. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia.
Scuteri D; Vulnera M; Piro B; Bossio RB; Morrone LA; Sandrini G; Tamburin S; Tonin P; Bagetta G; Corasaniti MT
Eur J Clin Pharmacol; 2021 Feb; 77(2):241-249. PubMed ID: 32935181
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal medication usage in Alzheimer disease patients.
Zhu CW; Livote EE; Kahle-Wrobleski K; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
Alzheimer Dis Assoc Disord; 2010; 24(4):354-9. PubMed ID: 20625271
[TBL] [Abstract][Full Text] [Related]
4. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing.
Blaszczyk AT; Mang BH; Garza H; Mathys M
Consult Pharm; 2018 May; 33(5):273-282. PubMed ID: 29789049
[TBL] [Abstract][Full Text] [Related]
6. The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database.
Lachaine J; Beauchemin C; Crochard A; Bineau S
Can J Psychiatry; 2013 Apr; 58(4):195-200. PubMed ID: 23547642
[TBL] [Abstract][Full Text] [Related]
7. Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units.
Nobili A; Pasina L; Trevisan S; Riva E; Lucca U; Tettamanti M; Matucci M; Tarantola M
Int Clin Psychopharmacol; 2009 Mar; 24(2):97-104. PubMed ID: 21456106
[TBL] [Abstract][Full Text] [Related]
8. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
[TBL] [Abstract][Full Text] [Related]
9. [Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics].
Girona-Brumós L; Ribera-Montañá R; Juárez-Giménez JC; Pilar Lalueza-Broto M
Gac Sanit; 2006 Mar; 20 Suppl 1():143-53. PubMed ID: 16539977
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
11. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
[TBL] [Abstract][Full Text] [Related]
13. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics.
van Dijk L; Heerdink ER; Somai D; van Dulmen S; Sluijs EM; de Ridder DT; Griens AM; Bensing JM
BMC Health Serv Res; 2007 Apr; 7():51. PubMed ID: 17425792
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin utilization among older adults with different cognitive statuses enrolled in the National Alzheimer's Coordinating Center (2006-2019).
Oh GY; Moga DC; Abner EL
Br J Clin Pharmacol; 2023 Jan; 89(1):410-415. PubMed ID: 36097795
[TBL] [Abstract][Full Text] [Related]
15. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.
Kettunen R; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Koponen M
Eur J Clin Pharmacol; 2019 Mar; 75(3):417-425. PubMed ID: 30413841
[TBL] [Abstract][Full Text] [Related]
16. [Symptomatic therapy of Alzheimer dementia].
Förstl H
Wien Med Wochenschr; 2002; 152(3-4):77-80. PubMed ID: 11925776
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
[TBL] [Abstract][Full Text] [Related]
18. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
[TBL] [Abstract][Full Text] [Related]
19. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
